genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2014
Otsuka Pharmaceutical
News
Otsuka to Acquire Avanir for $3.5B
Cancer
Otsuka Acquires Rights to Eisai Cancer Treatment
News
Lundbeck, Otsuka Expand Alzheimer’s Collaboration to Third Candidate
News
J&J Innovation Teams Up With Canada’s NEOMED, MaRS Innovation
Industry News
Otsuka Acquires Astex for $866M
News
Lundbeck and Otsuka Enter Alzheimer’s Alliance
News
Partnering Across the Pacific
News
Lundbeck Pays Otsuka $200M Up Front in CNS Drug Deal
News
Otsuka Buys Significant Stake in Living Cell Technologies with $3M
Cancer
BMS’ Sprycel Cleared in EU for Newly Diagnosed Ph+ CML Therapy
1
2
3
Page 2 of 3
Scroll Up
Scroll Up
